KR840005464A - 포스포리피드 유도체의 제조방법 - Google Patents
포스포리피드 유도체의 제조방법 Download PDFInfo
- Publication number
- KR840005464A KR840005464A KR1019830003406A KR830003406A KR840005464A KR 840005464 A KR840005464 A KR 840005464A KR 1019830003406 A KR1019830003406 A KR 1019830003406A KR 830003406 A KR830003406 A KR 830003406A KR 840005464 A KR840005464 A KR 840005464A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- salt
- alkoxy
- group
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003904 phospholipids Chemical class 0.000 title 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 9
- 125000003545 alkoxy group Chemical group 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 125000002723 alicyclic group Chemical group 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 125000004423 acyloxy group Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 150000002367 halogens Chemical group 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C07H11/04—Phosphates; Phosphites; Polyphosphates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 다음 구조식(Ⅱ)의 화합물 또는 그 염을 다음 구조식(Ⅲ)화합물 또는 그 염과 반응시켜서 다음 구조식(Ia)화합물 또는 그 염을 제조하거나 다음 구조식(Ⅳ)의 화합물을 다음 구조식(Ⅴ)의 화합물 또는 그 염과 반응시켜서 다음 구조식(Ib)의 화합물 또는 그 염을 제조하거나, 또는 다음 구조식(Ic)의 화합물 또는 그 염에서 보호기를 제거하여 다음 구조식(Id)의 화합물 또는 그 염을 제조함을 특징으로 하는 다음 구조식(I)의 화합물 또는 그 염을 제조하는 방법.
- (I)(Ⅱ)
- (Ⅲ)(Ia)
- (Ⅳ)(Ⅴ)
- (Ib)(Ic)
- (Id)
- 상기 식에서 R1은 알킬, 알콕시, 알킬티오 또는 알킬설포닐; R2는 수소, 하이드록시, 알콕시, 저급알카노일옥시 또는 저급알킬카바모일옥시; n은 0 또는 1 ;R3는 하이드록시 또는 보호된 하이드록시이며; R4는 저급알콕시; 2이상의 하이드록시 또는 보호된 하이드록시기로 치환된 저급알콕시 또는 저급 알리사이클릭옥시기; 저급알콕시 또는 2이상의 하이드록시기를 가지는 다른 알리사이클릭-옥시기로 치환된 저급알콕시 또는 저급알리사이클릭-옥시기, 알리사이클릭 링은 산소원자를 함유할 수 있다.
- R2 a는 수소, 알콕시, 저급알카노일옥시 또는 저급알킬카바모일옥시; R3 a는 보호된 하이드록시; X는 할로겐 또는 실버옥시; R4 a는 저급알킬; 또는 2이상의 보호된 하이드록시기로 치환되고, 저급알콕시, 또는 2이상의 보호된 하이드록시기를 가지는 다른 알리사이클릭-옥시기로 치환될 수도 있는 저급알리사이클릭기, 여기에서 알리사이클릭기는 하나의 산소원자를 함유할 수 있다.
- Y는 X가 할로겐인때 하이드록시기이거나, X가 실버옥시일때 할로겐이며; R3 b와 R4 b는 적어도 하나의 보호된 하이드록시기가 R3 b및 R4 b에 함유된 조건하에 각각 R3및 R4와 같으며; R3 c및 R4 c는 적어도 하나의 하이드록시기가 R3및 R4에 함유된 조건하에 R3및 R4와 같다.
- ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8222020 | 1982-07-30 | ||
GB8222020 | 1982-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR840005464A true KR840005464A (ko) | 1984-11-12 |
Family
ID=10532013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019830003406A KR840005464A (ko) | 1982-07-30 | 1983-07-23 | 포스포리피드 유도체의 제조방법 |
Country Status (6)
Country | Link |
---|---|
US (1) | US4585762A (ko) |
EP (1) | EP0100499A3 (ko) |
JP (1) | JPS5942394A (ko) |
KR (1) | KR840005464A (ko) |
DK (1) | DK347383A (ko) |
ES (3) | ES8501410A1 (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3239817A1 (de) * | 1982-07-06 | 1984-01-12 | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Neue glycerinderivate zur synthese von phospholipiden |
JPS6122096A (ja) * | 1984-07-09 | 1986-01-30 | Kao Corp | 糖リン酸エステルおよびその製造方法 |
IT1244546B (it) * | 1991-02-01 | 1994-07-15 | Mediolanum Farmaceutici Spa | Analoghi del fosfatidilinositolo inibitori della fosfolipasi c fosfatidilinositolo-specifica |
JP2553171Y2 (ja) * | 1991-05-31 | 1997-11-05 | 東陶機器株式会社 | 便器装置 |
SE9102068L (sv) * | 1991-07-03 | 1993-01-04 | Perstorp Ab | Derivat av inositol, kompositioner innehaallande dessa samt anvaendning daerav |
IT1255476B (it) * | 1992-07-30 | 1995-11-02 | Glicerofosfoderivati farmacologicamente attivi | |
DE4234130A1 (de) * | 1992-10-09 | 1994-04-14 | Max Planck Gesellschaft | Phospholipase A¶2¶ inhibierende Phosphatidylcholinverbindungen |
US5354853A (en) * | 1993-03-12 | 1994-10-11 | Genzyme Corporation | Phospholipid-saccharide conjugates |
WO1995007089A1 (en) | 1993-09-09 | 1995-03-16 | Imutec Corporation | Immunomodulating compositions from bile |
US6551623B1 (en) | 1993-09-09 | 2003-04-22 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
AU711294B2 (en) | 1995-03-16 | 1999-10-07 | Erin Mills Biotech Inc. | Immunomodulating compositions from bile for the treatment of immune system disorders |
US20040101569A1 (en) * | 1996-05-16 | 2004-05-27 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
CA2427352C (en) * | 2000-11-07 | 2010-10-12 | I.R.B. Istituto Di Ricerche Biotecnologiche S.R.L. | Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
EP1537129B1 (en) * | 2002-09-03 | 2013-11-06 | Georgetown University | Akt inhibitors, pharmaceutical compositions, and uses thereof |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2287901A1 (fr) * | 1974-10-14 | 1976-05-14 | Pasteur Institut | Medicament immunostimulant contenant un derive d'ose ou de polyose phosphoryle |
DE2659048A1 (de) * | 1976-12-27 | 1978-07-06 | Nattermann A & Cie | Neue inositphosphatid-derivate und verfahren zur herstellung dieser verbindungen |
-
1983
- 1983-07-13 US US06/513,451 patent/US4585762A/en not_active Expired - Fee Related
- 1983-07-23 KR KR1019830003406A patent/KR840005464A/ko not_active Application Discontinuation
- 1983-07-23 EP EP83107236A patent/EP0100499A3/en not_active Withdrawn
- 1983-07-28 DK DK347383A patent/DK347383A/da not_active Application Discontinuation
- 1983-07-29 ES ES524610A patent/ES8501410A1/es not_active Expired
- 1983-07-29 JP JP58139709A patent/JPS5942394A/ja active Pending
-
1984
- 1984-03-15 ES ES530668A patent/ES530668A0/es active Granted
- 1984-03-15 ES ES530669A patent/ES530669A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
DK347383A (da) | 1984-01-31 |
DK347383D0 (da) | 1983-07-28 |
EP0100499A3 (en) | 1985-06-12 |
ES8604243A1 (es) | 1985-07-01 |
ES530668A0 (es) | 1985-07-01 |
EP0100499A2 (en) | 1984-02-15 |
ES8602027A1 (es) | 1985-05-01 |
US4585762A (en) | 1986-04-29 |
ES524610A0 (es) | 1984-12-01 |
ES8501410A1 (es) | 1984-12-01 |
ES530669A0 (es) | 1985-05-01 |
JPS5942394A (ja) | 1984-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR840005464A (ko) | 포스포리피드 유도체의 제조방법 | |
KR830007643A (ko) | 벤조헤테로사이클 화합물의 제조방법 | |
KR860006452A (ko) | 피페리딘 화합물의 제조 방법 | |
KR830007570A (ko) | 아자비시클로-옥탄-카복실산의 제조방법 | |
KR850004492A (ko) | 옥시캄의 엔올 에테르 유도체의 제조방법 | |
KR840004737A (ko) | 6a,10a-트랜스-헥사하이드로디벤조피라논의 제조방법 | |
KR850001905A (ko) | 벤조시클로 알칸 유도체의 제조방법 | |
KR860000243A (ko) | 아민유도체의 제조방법 | |
KR850004754A (ko) | 3-인돌 카르복사미드 화합물류의 제조방법 | |
EP0247392A3 (en) | Anti treeing additives | |
KR850001746A (ko) | 퀴나졸린 화합물의 제조방법 | |
KR840005122A (ko) | 메틸플라본 유도체의 제조방법 | |
KR860001097A (ko) | 4-아미노-2-페닐퀴놀린의 제조방법 | |
KR860003202A (ko) | 요오드 트리아미노벤젠 화합물의 제조방법 | |
KR850002460A (ko) | 카르바메이트 화합물의 제조방법 | |
KR840005453A (ko) | 펜엠 유도체의 제조방법 | |
KR850001663A (ko) | 살충 및 응애류 박멸제 조성물 | |
KR840003606A (ko) | 판테놀 유도체의 제제 판테놀 유도체의 제제방법 | |
KR840006238A (ko) | 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법 | |
KR850002979A (ko) | 1,2,3-트리티안화합물의 신규 제조방법 | |
AU6658486A (en) | New anthracyclines and drugs containing them | |
KR840001578A (ko) | 9,10-치환된 2-메시틸이미노-3-알킬-3,4,6,7-테트라하이드로-2H-피리미도(6,1-a)이소퀴놀린-4-온의 제조방법 | |
KR840002351A (ko) | 치오알카노일-카르니틴의 제조방법 및 이를함유하는 점액분해 용약으로 제조된 조성물 | |
KR920008012A (ko) | 트리아졸 유도체 | |
KR850007247A (ko) | 바이페닐릴설포닐 우레아의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |